CureAge
1 known investors
CureAge develops genetic therapies to treat peripheral nerve diseases, specifically targeting Neurofibromatosis type 1. The company aims to translate genetic medicine into cures for patients with rare nerve disorders.
BiotechDigital HealthMedical Devices